Imaging the accumulation and suppression of tau pathology using multiparametric MRI

Neurobiology of Aging

Volumn 39, Issue , 2016, Pages 184-194

  Holmes, Holly E ^a   Colgan, Niall ^a   Ismail, Ozama ^a   Ma, Da ^a   Powell, Nick M ^a   O'Callaghan, James M ^a   Harrison, Ian F ^a   Johnson, Ross A ^b   Murray, Tracey K ^b   Ahmed, Zeshan ^b   Heggenes, Morton ^b   Fisher, Alice ^b   Cardoso, M J ^a   Modat, Marc ^a   Walker Samuel, Simon ^a   Fisher, Elizabeth M C ^c   Ourselin, Sebastien ^a   O'Neill, Michael J ^b   Wells, Jack A ^a   Collins, Emily C ^b   Lythgoe, Mark F ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Biomarker; In vivo; Longitudinal; MRI; Tauopathy

Indexed keywords

TAU PROTEIN; DOXYCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; HIPPOCAMPUS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TAUOPATHY; THALAMUS; ALZHEIMER DISEASE; ANIMAL; ATROPHY; BRAIN CORTEX; DISEASE MODEL; DRUG EFFECTS; GENETICS; LONGITUDINAL STUDY; MALE; METABOLISM; NEUROFIBRILLARY TANGLE; PATHOLOGY; PROCEDURES; TRANSGENE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ATROPHY; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOXYCYCLINE; FEMALE; HIPPOCAMPUS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; TAU PROTEINS; TAUOPATHIES; TRANSGENES;

EID: 84959539652     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.12.001     Document Type: Article

References (70)

1. Acosta-Cabronero J, Alley S., Williams G.B., Pengas G., Nestor P.J. Diffusion tensor Metrics as biomarkers in Alzheimer's disease. PLoS One 2012, 7:e49072.
2. Ahmed Z, Cooper J., Murray T.K., Garn K., McNaughton E., Clarke H., Parhizkar S., Ward M.A., Cavallini A., Jackson S., Bose S., Clavaguera F., Tolnay M., Lavenir I., Goedert M., Hutton M.L., O'Neill M.J. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 2014, 127:667-683.
3. Anand R., Gill K.D., Mahdi A.A. Therapeutics of Alzheimer's disease: past, present and future. Neuropharmacology 2014, 76, Part A:27-50.
4. Batchelor P.G, Atkinson D., Hill D.L.G., Calamante F., Connelly A. Anisotropic noise propagation in diffusion tensor MRI sampling schemes. Magn. Reson. Med. 2003, 49:1143-1151.
5. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278.
6. Brookmeyer R, Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007, 3:186-191.
7. Buxton R.B, Frank L.R., Wong E.C., Siewert B., Warach S., Edelman R.R. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn. Reson. Med. 1998, 40:383-396.
8. Cherubini A, Péran P., Spoletini I., Di Paola M., Di Iulio F., Hagberg G.E., Sancesario G., Gianni W., Bossù P., Caltagirone C., Sabatini U., Spalletta G. Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J. Alzheimers Dis. 2010, 19:1273-1282.
9. Constantinides C., Mean R., Janssen B.J. Effects of isoflurane anesthesia on the cardiovascular function of the C57BL/6 mouse. ILAR J. 2011, 52:e21-e31.
10. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3:184-190.
11. den Heijer T., der Lijn F.v., Vernooij M.W., de Groot M., Koudstaal P.J., der Lugt A.v., Krestin G.P., Hofman A., Niessen W.J., Breteler M.M.B. Structural and diffusion MRI measures of the hippocampus and memory performance. Neuroimage 2012, 63:1782-1789.
12. Drummond J.C, Todd M.M., Scheller M.S., Shapiro H.M. A comparison of the direct cerebral vasodilating potencies of halothane and isoflurane in the New Zealand White rabbit. Anesthesiology 1986, 65:462-467.
13. Fang B., Wang D., Huang M., Yu G., Li H. Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia. Int. J. Neurosci. 2010, 120:591-595.
14. Faure A, Verret L., Bozon B., El Tannir El Tayara N., Ly M., Kober F., Dhenain M., Rampon C., Delatour B. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease. Neurobiol. Aging 2011, 32:407-418.
15. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
16. Giacobini E., Gold G. Alzheimer disease therapy-moving from amyloid-[beta] to tau. Nat. Rev. Neurol. 2013, 9:677-686.
17. Giannakopoulos P, Herrmann F., Bussiere T., Bouras C., Kövari E., Perl D., Morrison J., Gold G., Hof P. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60:1495-1500.
18. Govaerts K, Himmelreich U., Leuven F.V., Dresselaers T. Perfusion and vascular response as early markers in a bigenic mouse model of Alzheimer's disease 2014, International Society of Magnetic Resonance in Medicine, Milan, Italy.
19. Gozzi A, Ceolin L., Schwarz A., Reese T., Bertani S., Crestan V., Bifone A. A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI. Magn. Reson. Imaging 2007, 25:826-833.
20. Hajjar I., Rodgers K. Do angiotensin receptor blockers prevent Alzheimer's disease?. Curr. Opin. Cardiol. 2013, 28:417-425.
21. Hall A.M., Roberson E.D. Mouse models of Alzheimer's disease. Brain Res. Bull. 2012, 88:3-12.
22. Huang H, Fan X., Weiner M., Martin-Cook K., Xiao G., Davis J., Devous M., Rosenberg R., Diaz-Arrastia R. Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization. Neurobiol. Aging 2012, 33:2029-2045.
23. Hugenschmidt C.E, Peiffer A.M., Kraft R.A., Casanova R., Deibler A.R., Burdette J.H., Maldjian J.A., Laurienti P.J. Relating imaging indices of white matter integrity and volume in healthy older adults. Cereb. Cortex 2008, 18:433-442.
24. Jack C.R, Dickson D.W., Parisi J.E., Xu Y.C., Cha R.H., O'Brien P.C., Edland S.D., Smith G.E., Boeve B.F., Tangalos E.G., Kokmen E., Petersen R.C. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002, 58:750-757.
25. Jack C.R, Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., L.Whitwell J., Ward C., Dale A.M., Felmlee J.P., Gunter J.L., Hill D.L.G., Killiany R., Schuff N., Fox-Bosetti S., Lin C., Studholme C., DeCarli C.S., Gunnar K., Ward H.A., Metzger G.J., Scott K.T., Mallozzi R., Blezek D., Levy J., Debbins J.P., Fleisher A.S., Albert M., Green R., Bartzokis G., Glover G., Mugler J., Weiner M.W. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27:685-691.
26. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
27. Jones C.K, Schlosser M.J., van Zijl P.C.M., Pomper M.G., Golay X., Zhou J. Amide proton transfer imaging of human brain tumors at 3T. Magn. Reson. Med. 2006, 56:585-592.
28. Jorge Cardoso M, Leung K., Modat M., Keihaninejad S., Cash D., Barnes J., Fox N.C., Ourselin S. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med. Image Anal. 2013, 17:671-684.
29. Kantarci K, Jack C.R., Xu Y.C., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., Petersen R.C. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 2001, 219:101-107.
30. Kerbler G.M, Hamlin A.S., Pannek K., Kurniawan N.D., Keller M.D., Rose S.E., Coulson E.J. Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model. Neuroimage 2013, 66:133-141.
31. Kim S.G. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn. Reson. Med. 1995, 34:293-301.
32. Kwong K.K, Belliveau J.W., Chesler D.A., Goldberg I.E., Weisskoff R.M., Poncelet B.P., Kennedy D.N., Hoppel B.E., Cohen M.S., Turner R. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5675-5679.
33. Le Bihan D, Mangin J.-F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 2001, 13:534-546.
34. Lerch J.P, Gazdzinski L., Germann J., Sled J.G., Henkelman R.M., Nieman B.J. Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse. Front. Neuroinformatics 2012, 6:6.
35. Ma D, Cardoso M.J., Modat M., Powell N., Wells J., Holmes H., Wiseman F., Tybulewicz V., Fisher E., Lythgoe M.F., Ourselin S. Automatic structural parcellation of mouse brain MRI using multi-atlas label fusion. PLoS One 2014, 9:e86576.
36. Ma Y, Smith D., Hof P.R., Foerster B., Hamilton S., Blackband S.J., Yu M., Benveniste H. In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Front. Neuroanat. 2008, 2:1.
37. Makaryus R, Lee H., Yu M., Zhang S., Smith S.D., Rebecchi M., Glass P.S., Benveniste H. The metabolomic profile during isoflurane anesthesia differs from propofol anesthesia in the live rodent brain. J. Cereb. Blood Flow Metab. 2011, 31:1432-1442.
38. Massaad C.A, Amin S.K., Hu L., Mei Y., Klann E., Pautler R.G. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One 2010, 5:e10561.
39. Matta B.F, Heath K.J., Tipping K., Summors A.C. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology 1999, 91:677.
40. McVicar N, Li A.X., Goncalves D.F., Bellyou M., Meakin S.O., Prado M.A.M., Bartha R. Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J. Cereb. Blood Flow Metab. 2014, 34:690-698.
41. Mielke M.M, Kozauer N.A., Chan K.C.G., George M., Toroney J., Zerrate M., Bandeen-Roche K., Wang M.C., vanZijl P., Pekar J.J., Mori S., Lyketsos C.G., Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 2009, 46:47-55.
42. Modat M, Ridgway G.R., Taylor Z.A., Lehmann M., Barnes J., Hawkes D.J., Fox N.C., Ourselin S. Fast free-form deformation using graphics processing units. Comput. Methods Programs Biomed. 2010, 98:278-284.
43. Modat M, Cardoso M.J., Daga P., Cash D., Fox N., Ourselin S. Inverse-consistent symmetric free form deformation. Biomedical image registration 2012, 79-88. Springer, Berlin, Germany. B. Dawant, G. Christensen, J.M. Fitzpatrick, D. Rueckert (Eds.).
44. Nyul L.G., Udupa J.K., Zhang X. New variants of a method of MRI scale standardization. IEEE Trans. Med. Imaging 2000, 19:143-150.
45. O'Callaghan J, Wells J., Richardson S., Holmes H., Yu Y., Walker-Samuel S., Siow B., Lythgoe M.F. Is your system calibrated? MRI gradient system calibration for pre-clinical, high-resolution imaging. PLoS One 2014, 9:e96568.
46. Ourselin S, Roche A., Prima S., Ayache N. Block matching: a general framework to improve robustness of rigid registration of medical images. Lecture Notes in Computer Science 2000, 1935:557-566. Springer, Berlin Heidelberg. L. Scott, M. Delp Anthony, DiGoia Branislav Jaramaz (Eds.).
47. Qin Y.-Y, Li M.-W., Zhang S., Zhang Y., Zhao L.-Y., Lei H., Oishi K., Zhu W.-Z. In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods. Neuroradiology 2013, 55:1027-1038.
48. Ramsden M, Kotilinek L., Forster C., Paulson J., McGowan E., SantaCruz K., Guimaraes A., Yue M., Lewis J., Carlson G., Hutton M., Ashe K.H. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 2005, 25:10637-10647.
49. Ruitenberg A, den Heijer T., Bakker S.L.M., van Swieten J.C., Koudstaal P.J., Hofman A., Breteler M.M.B. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann. Neurol. 2005, 57:789-794.
50. Sahara N, Perez P.D., Lin W.-L., Dickson D.W., Ren Y., Zeng H., Lewis J., Febo M. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study. Neurobiol. Aging 2014, 35:1364-1374.
51. SantaCruz K, Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
52. Scheidegger R., Vinogradov E., Alsop D.C. Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn. Reson. Med. 2011, 66:1275-1285.
53. Song S.K, Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17:1429-1436.
54. Song S.-K, Kim J.H., Lin S.-J., Brendza R.P., Holtzman D.M. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol. Dis. 2004, 15:640-647.
55. Stelzmann R.A., Norman Schnitzlein H., Reed Murtagh F. An English translation of Alzheimer's 1907 paper, "über eine eigenartige erkankung der hirnrinde.". Clin. Anat. 1995, 8:429-431.
56. Sun P.Z., Farrar C.T., Sorensen A.G. Correction for artifacts induced by B0 and B1 field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn. Reson. Med. 2007, 58:1207-1215.
57. Sykova E. Extrasynaptic volume transmission and diffusion parameters of the extracellular space. Neuroscience 2004, 129:861-876.
58. Tustison N.J, Avants B.B., Cook P.A., Zheng Y., Egan A., Yushkevich P.A., Gee J.C. N4ITK: improved N3 bias correction. Med. Imaging IEEE Trans. 2010, 29:1310-1320.
59. van Zijl P., Yadav N.N. Chemical exchange saturation transfer (CEST): what is in a name and what isn't?. Magn. Reson. Med. 2011, 65:927-948.
60. Villa F, Iacca C., Molinari A.F., Giussani C., Aletti G., Pesenti A., Citerio G. Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow. Crit. Care Med. 2012, 40:2797-2804.
61. Weidensteiner C, Metzger F., Bohrmann A.B.B., Kuennecke B., von Kienlin M. Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI. Magn. Reson. Med. 2009, 62:35-45.
62. Wells J.A, Siow B., Lythgoe M.F., Thomas D.L. The importance of RF bandwidth for effective tagging in pulsed arterial spin labeling MRI at 9.4T. NMR Biomed. 2012, 25:1139-1143.
63. Wells J.A, Holmes H.E., O'Callaghan J.M., Colgan N., Ismail O., Fisher E.M.C., Siow B., Murray T.K., Schwarz A.J., O'Neill M.J., Collins E.C., Lythgoe M.F. Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer/'s disease. J. Cereb. Blood Flow Metab. 2014, 111:369-378.
64. Wells J.A, O'Callaghan J.M., Holmes H.E., Powell N.M., Johnson R.A., Siow B., Torrealdea F., Ismail O., Walker-Samuel S., Golay X., Rega M., Richardson S., Modat M., Cardoso M.J., Ourselin S., Schwarz A.J., Ahmed Z., Murray T.K., O'Neill M.J., Collins E.C., Colgan N., Lythgoe M.F. In vivo imaging of tau pathology using multi-parametric quantitative MRI. Neuroimage 2015, 111:369-378.
65. Wolk D., Detre J. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr. Opin. Neurol. 2012, 25:421-428.
66. Yang D, Xie Z., Stephenson D., Morton D., Hicks C.D., Brown T.M., Sriram R., O'Neill S., Raunig D., Bocan T. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510). Neuroimage 2011, 54:2652-2658.
67. Yue M, Hanna A., Wilson J., Roder H., Janus C. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy. Neurobiol. Aging 2011, 32:590-603.
68. Zhou J, Lal B., Wilson D.A., Laterra J., van Zijl P.C.M. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn. Reson. Med. 2003, 50:1120-1126.
69. Zhou J, Payen J.F., Wilson D.A., Traystman R.J., van Zijl P.C.M. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 2003, 9:1085-1090.
70. Zhou J, Blakeley J.O., Hua J., Kim M., Laterra J., Pomper M.G., van Zijl P.C.M. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn. Reson. Med. 2008, 60:842-849.